Cargando…
Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant Proteins
G protein-coupled receptors (GPCRs), which includes the gonadotropin-releasing hormone (GnRH) receptor (GnRHR), comprises the largest family of validated drug targets – more than half of all approved drugs derive their benefits by selective targeting of GPCRs. Most drugs in this class are either ago...
Autores principales: | Conn, P. Michael, Janovick, Jo Ann |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103854/ https://www.ncbi.nlm.nih.gov/pubmed/21633718 http://dx.doi.org/10.3389/fendo.2011.00006 |
Ejemplares similares
-
Therapeutic Rescue of Misfolded Mutants: Validation of Primary High Throughput Screens for Identification of Pharmacoperone Drugs
por: Janovick, Jo Ann, et al.
Publicado: (2011) -
Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias
por: Janovick, Jo Ann, et al.
Publicado: (2017) -
Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants
por: Tao, Ya-Xiong, et al.
Publicado: (2014) -
OR03-01 Functional Rescue Of Trafficking-Defective Mutant Follicle-Stimulating Hormone Receptors (FSHR) Leading To Premature Ovarian Failure With The Pharmacoperone CAN1405
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2023) -
Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity
por: Smith, Emery, et al.
Publicado: (2020)